4080 Results
 
HIV/Aids

Campaigning for Access to Routine Viral Load Monitoring

The purpose of this Toolkit is to provide up to date information that provides the knowledge and skills needed to advocate for access to Routine Viral Load Testing (RVLT).
 Report - 1 Apr 2016
 
HIV/Aids

Campaigning for Access to Routine Viral Load Monitoring (PORTUGUESE)

The aim of the Activist Toolkit for Routine Viral Load Testing is to enable and mobilize PLHIV and activists to use science and evidence to persuasively and actively advocate to decision makers and service providers for access to, and availability of, affordable routine viral load testing for PLHIV.
 Report - 1 Apr 2016
 
HIV/Aids

Low coverage / Out of Focus (FRENCH)

Briefing Document - 1 Apr 2016
 
Central African Republic

Massive 8 - disease vaccination campaign in the Central African Republic

An unprecedented vaccination campaign is under way in the Central African Republic.
 Videos and Photos - 1 Apr 2016
 
Women carrying charcoal and firewood
Activity Report

MSF South Sudan activity update: March 2016

MSF operations in response to the medical needs in South Sudan.
 Report - 31 Mar 2016
 
Malaria

Lake Chad: trapped in deadly violence

Large-scale humanitarian needs go unmet as millions displaced by the ongoing crisis. 
 
 Latest News - 30 Mar 2016
 

Niger: Looking for a Safe Place to Live in Diffa

Videos and Photos - 30 Mar 2016
 

At EU-India Summit, India must defend its ‘pharmacy of the developing world’

MSF urges Indian Prime Minister not to cave into pressure from EU to accept trade deal that could harm access to medicines for millions of people
 Press Release - 29 Mar 2016
 
Central African Republic

Fieldworker: Venant Niyikiza “I didn’t join MSF for the money"

Meet Venant Niyikiza, MSF's fieldworker who has just returned from the Central African Republic (CAR).  
 Fieldworkers Stories - 25 Mar 2016
 
Drug-resistant TB

DR-TB drugs under the microscope

This report - now in its third edition - analyses the sources and prices of medicines used to treat drug-resistant TB (DR-TB), examines the key factors that shape the access environment for DR-TB medicines, reviews the research and development landscape for DR-TB treatment regimens, and makes recommendations for the way forward to reach more people and improve treatment outcomes. 
 Briefing Document - 24 Mar 2016